These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11119802)

  • 1. Immunologic monitoring: implications for treatment of rejection.
    Suthanthiran M
    Transplant Proc; 2000 Nov; 32(7):1493-4. PubMed ID: 11119802
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular correlates of human renal allograft rejection.
    Sharma VK; Ding R; Li B; Bologa RM; Lagman M; Eduafo A; Edouard P; Mouradian J; Strom TB; Suthanthiran M
    Transplant Proc; 1998 Aug; 30(5):2364-6. PubMed ID: 9723506
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrarenal display of cytotoxic attack molecules during rejection.
    Sharma VK; Bologa RM; Li B; Xu GP; Lagman M; Mouradian J; Wang J; Serur D; Rao VK; Suthanthiran M
    Transplant Proc; 1997; 29(1-2):1090-1. PubMed ID: 9123214
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative competitive polymerase chain reaction: design and synthesis of mRNA-specific competitor DNA templates and their clinical usage.
    Ding R; Li B; Sharma VK; Bologa RM; Lagman M; Mouradian J; Strom TB; Suthanthiran M
    Transplant Proc; 1998 Aug; 30(5):2370-2. PubMed ID: 9723508
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms and management of acute renal allograft rejection.
    Suthanthiran M; Strom TB
    Surg Clin North Am; 1998 Feb; 78(1):77-94. PubMed ID: 9531937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granzyme B, FAS-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation: comparison between blood and renal aspirates.
    Netto MV; Fonseca BA; Dantas M; Saber LT; Castro MC; Ferraz AS
    Transplant Proc; 2002 Mar; 34(2):476-8. PubMed ID: 12009596
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.
    Jeyarajah DR; Kadakia RA; O'Toole K; Newell KA; Josephson MA; Spargo BH; Woodle ES; Thistlethwaite JR
    Transplant Proc; 1995 Feb; 27(1):887-9. PubMed ID: 7879220
    [No Abstract]   [Full Text] [Related]  

  • 8. Late acute rejection in renal allograft recipients is mediated by inflammatory rather than by cytotoxic T-cell-dependent mechanisms.
    Ode-Hakim S; Döcke WD; Mutze S; volk HD; Reinke P
    Transplant Proc; 1997; 29(1-2):93-5. PubMed ID: 9123168
    [No Abstract]   [Full Text] [Related]  

  • 9. Human renal allograft rejection: molecular characterization.
    Suthanthiran M
    Nephrol Dial Transplant; 1998; 13 Suppl 1():21-4. PubMed ID: 9507493
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection.
    Suthanthiran M
    Kidney Int Suppl; 1997 Mar; 58():S15-21. PubMed ID: 9067937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune monitoring for rejection of kidney transplants.
    Soulillou JP
    N Engl J Med; 2001 Mar; 344(13):1006-7. PubMed ID: 11274628
    [No Abstract]   [Full Text] [Related]  

  • 12. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients.
    van den Boogaardt DE; van Miert PP; de Vaal YJ; de Fijter JW; Claas FH; Roelen DL
    Transplantation; 2006 Sep; 82(6):844-8. PubMed ID: 17006334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance.
    Desvaux D; Schwarzinger M; Pastural M; Baron C; Abtahi M; Berrehar F; Lim A; Lang P; le Gouvello S
    Transplantation; 2004 Sep; 78(5):647-53. PubMed ID: 15371663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ expression of cell growth factors in human renal chronic graft rejection.
    Vuillemin T; Legendre C; Meduri G; Larue JR; Goupy C; Kriaa F; Hiesse C; Benoit G; Senik A; Kreis H; Charpentier B
    Transplant Proc; 1997; 29(1-2):1513-4. PubMed ID: 9123405
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic parameters for the diagnosis of graft rejection.
    Hammer C; Reichenspurner H; Klima G
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):26-9. PubMed ID: 8351710
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of antirejection therapy on HLA-DR antigens and ICAM-1 expression on parenchymal cells as monitored by fine needle aspiration biopsy.
    Lodererová A; Lácha J; Chalupná J; Josková J
    Transplant Proc; 1998 Jun; 30(4):1176-7. PubMed ID: 9636475
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic rejection and cell growth factors.
    Vuillemin T; Legendre C; Meduri G; Larue JR; Goupy C; Kriaa F; Hiesse C; Benoit G; Senik A; Kreis H; Charpentier B
    Transplant Proc; 1996 Oct; 28(5):2831-2. PubMed ID: 8908085
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunomonitoring of renal transplant recipients in the early posttransplant period by analysis of cytokine gene expression in peripheral blood mononuclear cells.
    Gibbs PJ; Sadek SA; Cameron C; Tan LC; Howell WM
    Transplant Proc; 2001; 33(7-8):3285. PubMed ID: 11750406
    [No Abstract]   [Full Text] [Related]  

  • 19. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection.
    Grimbert P; Mansour H; Desvaux D; Roudot-Thoraval F; Audard V; Dahan K; Berrehar F; Dehoulle-Poillet C; Farcet JP; Lang P; Le Gouvello S
    Transplantation; 2007 Feb; 83(3):341-6. PubMed ID: 17297410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell immune monitoring in organ transplantation.
    Dinavahi R; Heeger PS
    Transplantation; 2009 Nov; 88(10):1157-8. PubMed ID: 19935367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.